Automated Microbiology Market by Component (Hardware, Services, Software), End-User (Agriculture, Education & Academic Institutions, Environmental Monitoring) - Global Forecast 2024-2030

Automated Microbiology Market by Component (Hardware, Services, Software), End-User (Agriculture, Education & Academic Institutions, Environmental Monitoring) - Global Forecast 2024-2030

The Automated Microbiology Market size was estimated at USD 11.27 billion in 2023 and expected to reach USD 12.51 billion in 2024, at a CAGR 11.87% to reach USD 24.74 billion by 2030.

Automated microbiology is a sector within microbiology that employs technology-driven processes and equipment to enhance the speed, accuracy, and efficiency of microbial analyses. This includes the use of automated systems for the detection, enumeration, and identification of microorganisms in various samples. Through advanced software, robotics, and sophisticated culture methods, automated microbiology minimizes human error, reduces manual labor, and accelerates diagnostic and research outcomes. The expansion of automated microbiology is primarily propelled by the increasing demand for rapid microbiological testing methods in industries such as healthcare, food and beverage, and pharmaceuticals. The escalating need for more efficient diagnostics, coupled with advancements in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), significantly drive the market's growth. Additionally, the rising prevalence of infectious diseases and the growing importance placed on food safety standards further contribute to the sector's expansion. High capital investments required for the installation of advanced automated systems hamper the growth of the market. Additionally, the complexity of microbial testing and the need for highly skilled personnel to operate sophisticated automated systems further limit market expansion. The integration of artificial intelligence and machine learning into microbiological testing processes offers new opportunities for innovation and improvement, enhancing the market's potential for growth.

Regional Insights

The Americas represent a significant market for automated microbiology due to advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of leading market players. The United States is a dominant force in this region, driven by a high adoption rate of automated solutions in diagnostic laboratories and ongoing investments in healthcare technology research and development. South America is also witnessing growth fueled by improving healthcare facilities, rising awareness of infectious diseases, and the gradual adoption of automated systems in countries like Brazil and Mexico. The APAC region is emerging as a rapidly growing market for automated microbiology, attributed to its vast population, increasing healthcare spending, and growing prevalence of infectious diseases. Countries such as China and India are at the forefront, leveraging their expanding healthcare infrastructure and increased investments in healthcare technology. Additionally, the region’s focus on research and development activities, coupled with government initiatives to modernize healthcare services, is propelling the adoption of automated microbiology solutions. Europe holds a significant position in the global automated microbiology market, driven by well-established healthcare systems, strong regulatory frameworks, and high awareness levels regarding advanced diagnostic methods. Germany, the United Kingdom, and France are key contributors, with a high demand for automated systems in clinical diagnostics. The Middle East and Africa (MEA) region is experiencing growth due to increasing healthcare investments, especially in the Gulf Cooperation Council (GCC) countries, focusing on healthcare infrastructure improvements and advancements in technology.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Automated Microbiology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Escalating need for efficient diagnostics to manage growing chronic diseases
• Increasing demand for rapid microbiological testing methods in food & beverage

Market Restraints

• High cost of integration of automated microbiology solutions

Market Opportunities

• Growing introduction of technological advanced automated microbiology solutions with enhanced accuracy and efficiency
• Rising government support for adoption of automated technologies across healthcare and laboratories

Market Challenges

• Privacy and security issues with automated microbiology solutions

Market Segmentation Analysis

• Component: Growing usage of automated microbiology testing software to capture and analyze images of microbial cultures
• End-User: High potential of automated microbiology in hospital & clinical laboratories reducing manual errors and improving turnaround times

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Automated Microbiology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Automated Microbiology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

County Approves Funds to Expand FCPD’s Automatic License Plate Reader Program

Fairfax County enhanced its law enforcement capabilities through the expansion of its automated license plate readers (ALPR) program, following the Board of Supervisors' approval of a significant grant. Garnering USD 136,270 in funding from the U.S. Department of Justice, this initiative aims to bolster the Fairfax County Police Department's resources in combating the increasing instances of violent carjackings and vehicle thefts. This strategic move underscores the county's commitment to leveraging modern technology in ensuring public safety and addressing critical crime trends effectively.

London’s Hospitals Adopting Clinical Microbiology with a World-first Installation of State-of-the-art Automated Laboratory Technology

London Health Sciences Centre (LHSC) along with St. Joseph’s Health Care London (St. Joseph’s) heralds the introduction of Total Laboratory Automation (TLA) within its clinical microbiology laboratory. This state-of-the-art system marks a significant leap forward in the realm of clinical microbiology, positioning London as a global benchmark for technological advancements in this field. The TLA system, unparalleled globally, signifies a major enhancement, not only in lab capacity but also in the precision and speed of infectious disease detection. Nested within the collaborative framework of Pathology and Laboratory Medicine (PaLM)—a partnership between LHSC and St. Joseph’s that offers extensive diagnostic and consultative services across Southwestern Ontario—this pioneering technology exemplifies a fusion of automation with expert human acumen. In doing so, it promises to elevate the standard of patient care to unprecedented levels, reinforcing London’s status as an epicenter of clinical microbiology innovation.

BD Introduces Fully Automated Robotic Track System for Microbiology Labs

Becton, Dickinson, and Company unveiled a groundbreaking robotic track system for the BD Kiestra microbiology laboratory solution, revolutionizing specimen processing through automation. This pioneering BD Kiestra 3rd Generation Total Lab Automation System empowers laboratories with customization capabilities, allowing them to tailor a comprehensive lab automation setup. Featuring a variety of track configurations and a selection of instruments, laboratories have the flexibility to determine their point of entry into automation, ensuring the system aligns with their workflow and spatial constraints.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Automated Microbiology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Automated Microbiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BIOMÉRIEUX, bioMérieux Industry, bioMérieux SA, Bruker Corporation, Cepheid Inc., Copan Diagnostics Inc., Danaher Corporation, Hardy Diagnostics, Labcompare, Luminex Corporation, Merck KGaA, Neogen Corporation, PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Whitelake Software Point Oy.

Market Segmentation & Coverage

This research report categorizes the Automated Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Component
• Hardware
• Automated Incubators
• Bacterial Colony Pickers
• Imaging Systems
• Plate Reader
• Specimen Processors
• Services
• Software
• End-User
• Agriculture
• Education & Academic Institutions
• Environmental Monitoring
• Food & Beverage
• Hospital & Clinical Laboratories
• Pharmaceutical & Biotechnology Firms
• Region
• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year